Role of cholecystokinin in canine pancreatic exocrine response to bombesin stimulation

William H. Nealon, R. Daniel Beauchamp, Courtney Townsend, James C. Thompson

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The role of cholecystokinin in bombesin-stimulated pancreatic secretion in dogs was examined by the use of a specific cholecystokinin antagonist, proglumide. The primary component of bombesin-stimulated pancreatic secretion at the lowest tested dose was due to cholecystokinin, with only 25 percent of bombesin-stimulated protein output preserved during proglumide infusion. Maximal stimulation of cholecystokinin release was achieved by even the lowest dose of bombesin, whereas dose-related increases in bombesin-stimulated protein secretion were observed. This increase in exocrine secretion is probably explained by increased direct bombesin stimulation. Our findings suggest that the maximal dose of bombesin is lower for cholecystokinin release than its effective dose for enzyme secretion. We conclude that, in all probability, postprandial release of bombesin (or its analogue, gastrin-releasing peptide) affects pancreatic function primarily through release of cholecystokinin.

Original languageEnglish (US)
Pages (from-to)96-101
Number of pages6
JournalThe American Journal of Surgery
Volume153
Issue number1
DOIs
StatePublished - 1987
Externally publishedYes

Fingerprint

Bombesin
Cholecystokinin
Canidae
Proglumide
Gastrin-Releasing Peptide
Proteins
Dogs
Enzymes

ASJC Scopus subject areas

  • Surgery

Cite this

Role of cholecystokinin in canine pancreatic exocrine response to bombesin stimulation. / Nealon, William H.; Beauchamp, R. Daniel; Townsend, Courtney; Thompson, James C.

In: The American Journal of Surgery, Vol. 153, No. 1, 1987, p. 96-101.

Research output: Contribution to journalArticle

Nealon, William H. ; Beauchamp, R. Daniel ; Townsend, Courtney ; Thompson, James C. / Role of cholecystokinin in canine pancreatic exocrine response to bombesin stimulation. In: The American Journal of Surgery. 1987 ; Vol. 153, No. 1. pp. 96-101.
@article{b539c2f32bb7408ebc2064d2ba67a365,
title = "Role of cholecystokinin in canine pancreatic exocrine response to bombesin stimulation",
abstract = "The role of cholecystokinin in bombesin-stimulated pancreatic secretion in dogs was examined by the use of a specific cholecystokinin antagonist, proglumide. The primary component of bombesin-stimulated pancreatic secretion at the lowest tested dose was due to cholecystokinin, with only 25 percent of bombesin-stimulated protein output preserved during proglumide infusion. Maximal stimulation of cholecystokinin release was achieved by even the lowest dose of bombesin, whereas dose-related increases in bombesin-stimulated protein secretion were observed. This increase in exocrine secretion is probably explained by increased direct bombesin stimulation. Our findings suggest that the maximal dose of bombesin is lower for cholecystokinin release than its effective dose for enzyme secretion. We conclude that, in all probability, postprandial release of bombesin (or its analogue, gastrin-releasing peptide) affects pancreatic function primarily through release of cholecystokinin.",
author = "Nealon, {William H.} and Beauchamp, {R. Daniel} and Courtney Townsend and Thompson, {James C.}",
year = "1987",
doi = "10.1016/0002-9610(87)90208-X",
language = "English (US)",
volume = "153",
pages = "96--101",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Role of cholecystokinin in canine pancreatic exocrine response to bombesin stimulation

AU - Nealon, William H.

AU - Beauchamp, R. Daniel

AU - Townsend, Courtney

AU - Thompson, James C.

PY - 1987

Y1 - 1987

N2 - The role of cholecystokinin in bombesin-stimulated pancreatic secretion in dogs was examined by the use of a specific cholecystokinin antagonist, proglumide. The primary component of bombesin-stimulated pancreatic secretion at the lowest tested dose was due to cholecystokinin, with only 25 percent of bombesin-stimulated protein output preserved during proglumide infusion. Maximal stimulation of cholecystokinin release was achieved by even the lowest dose of bombesin, whereas dose-related increases in bombesin-stimulated protein secretion were observed. This increase in exocrine secretion is probably explained by increased direct bombesin stimulation. Our findings suggest that the maximal dose of bombesin is lower for cholecystokinin release than its effective dose for enzyme secretion. We conclude that, in all probability, postprandial release of bombesin (or its analogue, gastrin-releasing peptide) affects pancreatic function primarily through release of cholecystokinin.

AB - The role of cholecystokinin in bombesin-stimulated pancreatic secretion in dogs was examined by the use of a specific cholecystokinin antagonist, proglumide. The primary component of bombesin-stimulated pancreatic secretion at the lowest tested dose was due to cholecystokinin, with only 25 percent of bombesin-stimulated protein output preserved during proglumide infusion. Maximal stimulation of cholecystokinin release was achieved by even the lowest dose of bombesin, whereas dose-related increases in bombesin-stimulated protein secretion were observed. This increase in exocrine secretion is probably explained by increased direct bombesin stimulation. Our findings suggest that the maximal dose of bombesin is lower for cholecystokinin release than its effective dose for enzyme secretion. We conclude that, in all probability, postprandial release of bombesin (or its analogue, gastrin-releasing peptide) affects pancreatic function primarily through release of cholecystokinin.

UR - http://www.scopus.com/inward/record.url?scp=0023104033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023104033&partnerID=8YFLogxK

U2 - 10.1016/0002-9610(87)90208-X

DO - 10.1016/0002-9610(87)90208-X

M3 - Article

VL - 153

SP - 96

EP - 101

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 1

ER -